Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Clinical trial NCT04420754 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04420754
Sponsor: AffyImmune Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Anaplastic Thyroid Cancer Relapsed/Refractory Poorly Differentiated Thyroid Cancer

Start date: 2020-09-28
Primary completion: 2026-08-04
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.